These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 1988578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K.
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [Abstract] [Full Text] [Related]

  • 7. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A, Miyazawa T, Miyazu Y, Iwamoto Y, Zaima M, Kanoh K, Sumiyoshi H, Doi M.
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
    Rusch V, Saltz L, Venkatraman E, Ginsberg R, McCormack P, Burt M, Markman M, Kelsen D.
    J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
    [Abstract] [Full Text] [Related]

  • 13. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N, Li X, Li F, Zhao H, Fan Z, Ma J, Fu Y, Kang H.
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.
    Jiang L, Li P, Gong Z, Hu B, Ma J, Wang J, Chu H, Zhang L, Sun P, Chen J.
    Anticancer Res; 2016 Mar; 36(3):1313-8. PubMed ID: 26977031
    [Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Chest; 2001 Feb; 119(2):340-3. PubMed ID: 11171707
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H, Ishida H, Nitanda H, Yamazaki N, Kaneko K, Kobayashi K.
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile.
    Nakano T, Chahinian AP, Shinjo M, Togawa N, Tonomura A, Miyake M, Ninomiya K, Yamamoto T, Higashino K.
    Cancer; 1999 Jun 01; 85(11):2375-84. PubMed ID: 10357408
    [Abstract] [Full Text] [Related]

  • 19. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S, Terman DS, Bohach G, Silvers A, Hansen C, Colt H, Sahn SA.
    Chest; 2004 Nov 01; 126(5):1529-39. PubMed ID: 15539723
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T, Takahashi N, Terakado M, Sato M, Sugane T, Kisohara A, Akusawa H, Tsujino I, Horie T.
    Gan To Kagaku Ryoho; 2005 Aug 01; 32(8):1139-43. PubMed ID: 16121916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.